Health Care Deal News- October 29, 2012


Brought to you by

October 29, 2012 Issue:


  1. Recent Health Care M&A Deals 
  2. Spotlight on: Venture Capital
  3. Spotlight on: Pharmaceuticals
  4. Webcast Calendar


Recent Health Care M&A Deals






 St. Vincent's Health System






 McKesson Corp.

 PSS World Medical


 C.R. Bard

 Neomend, Inc.






 Pfizer, Inc.

 NextWave Pharmaceuticals


 Dr. Reddy's Laboratories Limited

 OctoPlus N.V.



Capital Roundtable Conference: Private Equity Investing In Middle-Market Private Equity Healthcare Services Companies
Thursday, November 15, 2012, 7:30 am-5:00 pm ET
Regardless of November’s election results, healthcare services in the U.S. will never be the same. As a result, private equity firms are scrambling to identify who the leading providers will be, and how they can be matched with the right insurers, hospitals, group practices, and other players. From urgent care centers to nursing schools to rehab clinics, opportunities for superior returns are plentiful. Chairing this ALL-NEW conference, we are very happy to welcome, Scott A. Perricelli, Partner, LLR Partners Inc. Along with Scott, we’ll have a team of 20 knowledgeable panelists who are among the leaders in achieving outstanding investment results.  Go to: to register.


Spotlight on: Venture Capital
Is the IPO market opening up a bit for biotech and small pharmaceutical companies?  The venture capital community certainly hopes so, especially as third quarter M&A activity took a dip this year from both the second quarter and last year’s third quarter. As we were going to print, Regulus Therapeutics (NASDAQ: RGLS) priced its 11.25 million share IPO at $4.00 per share with Lazard Capital Markets, Cowen and Company and BMO Capital Markets as the joint book-running managers.....Read more


AVAILABLE NOW - New Sector M&A Reports!
Our team of experts at The Health Care M&A Information Source has been working around the clock to bring you the inside scoop on the latest in the health care M&A market. Our newest M&A reports are loaded with crucial transaction information, current and historic, to help you make smart investment decisions in these health care sectors: Biotechnology; Home Health and Hospice; Hospital; Managed Care; Medical Device; Not-for-Profit Health Care; and Pharmaceutical.


Spotlight on: Pharmaceuticals
Last month we wrote about one of the largest pharmaceutical deals of the summer, which was Valeant Pharmaceuticals International’s (NYSE: VRX) acquisition of Medicis Pharmaceutical Corporation (NYSE: MRX) for $2.6 billion. Since then, it has been a relatively lackluster market.  Other than the Medicis deal, which was announced over the Labor Day weekend, the transactions have been relatively small......Read more

Conference Calendar...Click here to see more